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Background: Transcranial Doppler (TCD) CO2-reactivity and oxygen-15 positron emission tomography (PET) have both
been used to measure the cerebral haemodynamic state in patients who may have a compromised blood flow. Our
purpose was to investigate whether PET and TCD identify the same patients with an impaired flow state of the brain in
patients with internal carotid artery (ICA) occlusion.
Methods: Patients with recent transient ischaemic attack or minor ischaemic stroke associated with ICA occlusion
underwent TCD with measurement of CO2-reactivity and oxygen-15 PET within a median time interval of 6 days.
Results: We included 24 patients (mean age 64±10 years). Seventeen (71%) patients had impaired CO2-reactivity (≤20%),
of whom six had absent reactivity (0%) or steal (<0%) in the hemisphere ipsilateral to the ICA occlusion. PET of the
perfusion state of the hemisphere ipsilateral to the ICA occlusion demonstrated stage 1 haemodynamic compromise
(decreased cerebral blood flow (CBF) or increased cerebral blood volume (CBV) without increased oxygen extraction
fraction (OEF)) in 13 patients and stage 2 (increased OEF) in 2 patients. In 12 patients (50%), there was agreement
between TCD and PET, indicating haemodynamic compromise in 10 and a normal flow state of the brain in 2 patients.
There was no significant correlation between CO2-reactivity and CBF ipsilateral/contralateral hemispheric ratio (r=0.168, p
value=0.432), OEF ratio (r=−0.242, p value=0.255), or CBV/CBF ratio (r=−0.368, p value=0.077).
Conclusions: In patients with symptomatic ICA occlusion, identification of an impaired flow state of the brain by PET and
TCD CO2-reactivity shows concordance in only half of the patients.
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The risk of recurrent ischaemic stroke in patients who
present with transient ischaemic attack (TIA) or ischaemic
stroke, associated with an internal carotid artery (ICA) oc-
clusion, may be as high as 12% per year in case of a demon-
strated compromised flow to the brain [1-3]. Because of* Correspondence: s.persoon@umcutrecht.nl
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in any medium, provided the original work is pthis increased risk, revascularization surgery has been con-
sidered in these patients. ‘The Carotid Occlusion Surgery
Study’ used PET to select patients with symptomatic ICA
occlusion and high oxygen extraction fraction (OEF) for in-
clusion in their study that aimed to investigate whether
extracranial-intracranial (EC/IC) bypass surgery prevents
recurrent stroke [4]. The results showed that the 2-year risk
of ipsilateral stroke did not differ between the surgical and
non-surgical group (p=0.78) despite an improvement in
OEF ratio and a bypass patency of 96% at the last follow up
[5]. Other types of revascularization, such as carotidan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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external carotid artery, or surgery or stenting of the verte-
bral artery, for patients with symptomatic ICA occlusion
may be considered as well, although firm evidence that
these treatments reduce the risk of stroke is lacking [1,6-8].
The haemodynamic state of the brain can be subdivided
into stage 0, the normal flow state of the brain; stage 1, the
phase of vasodilatation to compensate for a decrease in
blood flow towards the brain through cerebral autoregula-
tion; and stage 2, the phase of autoregulation failure, with a
compensatory rise in OEF [9]. Haemodynamic compromise
stage 2 can only be demonstrated by positron emission
tomography (PET) using oxygen-15-labelled tracers [10].
Previous oxygen-15 PET studies of patients with symptom-
atic ICA occlusion have shown a 2-year risk between 25%
and 75% of recurrent ischaemic stroke in those with an
increased OEF in comparison with a risk between 5% and
10% in patients without an increased OEF [2,3]. A disad-
vantage of PET scans with O-15 tracers is that this tech-
nique is not widely available and has a failure rate between
20% and 40% for obtaining complete quantitative data,
mostly due to technical difficulties [2,9,11,12]. A widely
available and cheap alternative for identification of patients
with haemodynamic compromise is transcranial Doppler
(TCD) with measurement of cerebrovascular reactivity
[13,14]. Although cerebrovascular reactivity cannot identify
patients with haemodynamic stage 2, it allows distinction
between normal and a compromised haemodynamic state.
Little is known about the agreement between oxygen-15
PET and TCD CO2-reactivity. If these two methods would
identify the same patients as being at risk of future stroke,
clinical trials may not need to be restricted to centres with
PET facilities. The purpose of this study was to investigate
whether, in patients with recent TIA or stroke associated
with ICA occlusion, oxygen-15 PET parameters and TCD
CO2-reactivity identify the same patients as having an
impaired flow state of the brain.
Methods
Patients
We prospectively included 24 patients referred to the De-
partment of Neurology, University Medical Center Utrecht,
the Netherlands, between December 2004 and September
2009. Patients were included if they had transient or, at
most, moderately disabling (modified Rankin scale≤3) [15]
neurological deficits associated with an ICA occlusion in
the previous 3 months and complete oxygen-15 H2O, O2
and CO PET and TCD CO2-reactivity studies. Contrast
angiography was performed to confirm occlusion of the
ICA and to study collateral pathways [16]. Patients were
excluded if there was evidence of arterial dissection or radi-
ation vasculopathy as cause of the occlusion of the ICA.
Magnetic resonance imaging of the brain was performed to
investigate the presence of ischaemic lesions and included athree dimensional (3D) T1 image needed for PET image
analysis. Six patients were excluded because of incomplete
PET data due to either failure to insert the arterial cannula
(n=3) or technical difficulties (n=3). Two other patients
were excluded because TCD measurement failed due to an
absent temporal bone window.
The institutional medical review board of the University
Medical Center Utrecht approved the study protocol. All
patients provided written informed consent.
TCD CO2-reactivity
CO2-reactivity was measured by TCD using a Multi-Dop
X device (DWL, Sipplingen, Germany) with two 2-MHz
pulsed Doppler probes for insonation of cerebral vessels
and a 4-MHz probe for the ophthalmic artery, as described
previously [17]. After a standard TCD to locate the cere-
bral vessels, CO2-reactivity was measured simultaneously
in both middle cerebral arteries (MCAs). Hypercapnia was
induced by inhalation of a gas mixture containing 5% CO2
and 95% O2 (carbogene) through a mouthpiece connected
to a respiratory balloon. A nose-clip ensured proper inhal-
ation of carbogene. A spectral TCD recording of 5-s dur-
ation was acquired after breathing room air for 1 min and
inhaling carbogene for 1.5 min. Readings of end-tidal CO2
and blood pressure were taken just before carbogene in-
halation and after 1.5 min. The average change in end-
tidal pCO2 was 12 mmHg (standard deviation (SD),
6 mmHg). CO2-reactivity after carbogene inhalation was
calculated as the relative (percentage) change in blood
flow velocity (BFV) in the MCA from the mean baseline
BFV, expressed as a percentage. CO2-reactivity≤ 20% was
considered as decreased as 20% corresponds with the
mean CO2-reactivity minus 2 standard deviations in nor-
mal controls [18]. A CO2-reactivity of 0% was defined as
absent reactivity and <0% as steal of blood flow from the
hemisphere ipsilateral to the ICA occlusion by other areas.
Positron emission tomography imaging
PET scans were acquired using an ECAT EXACT HR+
scanner (CTI/Siemens, Knoxville, Tennessee) [19]. Each
PET study consisted of three parts: (1) a dynamic emis-
sion scan (25 frames over 600 s) after intravenous ad-
ministration of a bolus of 1,100 MBq [15O]H2O to
measure cerebral blood flow (CBF), (2) a dynamic emis-
sion scan (20 frames over 600 s) after a 30-s net inhal-
ation of approximately 300 MBq [15O]O2 gas through a
nasal cannula to derive oxygen consumption and calcu-
late OEF, and (3) an emission scan (3 frames over 360 s)
following a net inhalation of approximately 200 MBq
[15O]CO gas to measure cerebral blood volume (CBV).
All emission scans were collected in 3D acquisition
mode. To allow for radioactive decay, an additional 5-
min period between scans was included so that each
administration was 15 min after the previous one.
Table 1 Clinical characteristics of patients with a
symptomatic ICA occlusion (n=24)
Characteristics Number of
patients (%)
Age (years, mean± SD) 64 ±10
Male 20 (83)
Clinical features at presentation:
cerebral TIA 17 (71)
ischaemic stroke 7 (29)
Repeated symptoms after documented occlusion 22 (92)
Systolic blood pressure (mmHg, mean± SD) 158 ±28
Diastolic blood pressure (mmHg, mean± SD) 86 ±14
Vascular risk factors:
Hypertensiona 20 (83)
Hyperlipidaemiab 22 (92)
Diabetes mellitus 6 (25)
Cigarette smoking (current or in last 5 years) 13 (54)
History of stroke> 3 months ago 7 (29)
History of ischaemic heart disease 8 (33)
MRI:
Ischaemic lesions in MCA territory ipsilateral
to ICA occlusion:
11 (45)
endzone branche 3
large subcortical (> 1.5 mm) 3
cortical borderzone 5
Angiogram:
Bilateral ICA occlusion 1 (4)
Contralateral ICA stenosis ≥50% 9 (38)
Ipsilateral ECA stenosis ≥50% 6 (25)
Vertebral artery stenosis ≥50% 9 (38)
Collateral flow via anterior communicating artery 22 (92)
Collateral flow via ophthalmic artery 11 (46)
Collateral flow via posterior communicating arteryc 20 (83)
Leptomeningeal collateralsd 17 (71)
aHypertension was defined as blood pressure> 160/95 mmHg or current use
of antihypertensive medication. bHyperlipidaemia was defined as either a
history of hyperlipidaemia, current use on statins or levels of total cholesterol,
triglycerids or high density lipoprotein cholesterol outside the normal ranges.
cPresence of collateral flow via the posterior communicating artery could not
be judged in 1 patient. dPresence of leptomeningeal collaterals could not be
judged in 1 patient.
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attenuation and scatter correction purposes of the
emission scans. All scans were reconstructed using a
standard FORE+2D filtered backprojection algorithm with
a Hanning filter at Nyquist frequency. The arterial input
function was measured continuously using an online blood
sampling device [20]. In addition, at set times, manual sam-
ples were taken for calibration purposes and for assessment
of plasma to whole blood ratios. Finally, the average arterial
oxygen content was derived from blood gas analysis of
three arterial samples. Further details of the scanning pro-
cedure can be found elsewhere [12]. Normal CBF, OEF, and
CBV values were derived from 14 scans in seven healthy
subjects (mean age 66±7 years; five men) who underwent
a PET scan on two separate occasions with a median time
interval of 7 days, as published previously [12]. Mean values
of both scans for each healthy subject were used, and the
standard deviation was calculated. CBF, OEF, and CBV
values in patients were considered to be abnormal if they
were beyond mean values of normal controls ±1.96 times
the SD.
Image analysis
Individual anatomical 3D T1 MR images were co-registered
using summed [15O]H2O images. A standard template of
flow territories of middle cerebral artery, anterior cerebral ar-
tery, and posterior cerebral artery [21] was warped onto the
co-registered MR image using Automated Image Registration
software [22], applying a non-rigid 12-parameter perspective
warping. Statistical Parametric Mapping (SPM02, London,
UK, application in Matlab 7.0.4; MathWorks, Inc., Natick,
MD, USA) was used for segmentation of grey and white mat-
ter. Areas of infarction were excluded manually. Parametric
CBF, OEF and CBV images were generated using in-house
developed software (written in IDL, 6.2, ITT, Boulder CO,
USA) [23].
Data analysis
Patients were divided into haemodynamic stages based on
their values in the grey matter of the MCA territory: patients
with normal CBF (≥31.1 mL/min/100 mL), normal CBV
(≤3.9 mL/100 mL), and normal OEF (≤55.7%) were classified
as haemodynamic stage 0; patients with either decreased CBF
or increased CBV (both signs of autoregulation), but normal
OEF, as haemodynamic stage 1; and patients with increased
OEF (>55.7%) as haemodynamic stage 2. In addition, CBV/
CBF was calculated as a measurement of mean transit time.
Absolute CBF, OEF, and CBV/CBF values in the MCA terri-
tory, together with their hemispheric ratios (ipsilateral/contra-
lateral), were compared in patients with and without absent
CO2-reactivity or steal (CO2-reactivity≤0%) using the Stu-
dent’s t test or, in case of non-parametric variables, the
Mann–Whitney U test. The same analysis was performed in
patients with and without decreased CO2-reactivity (CO2-reactivity≤20%). In addition, Pearson or, in case of non-
parametric variables, Spearman correlation coefficients
were calculated to assess relationships of CBF, OEF, and
CBV/CBF with CO2-reactivity.
Results
Clinical characteristics and angiogram findings of the 24
patients are shown in Table 1. The mean time between last
symptoms and TCD was 33±25 days. The median time
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0 OEFCBF
Figure 1 Parametric images of cerebral blood flow and oxygen extraction fraction. Parametric images of cerebral blood flow (CBF) and
oxygen extraction fraction (OEF) measured using PET in a 69-year-old man who presented with a minor ischaemic stroke in the left hemisphere
with an occlusion of the left internal carotid artery. PET images show decreased CBF and increased OEF in the left hemisphere, indicating
haemodynamic failure (stage 2). Using transcranial Doppler, CO2-reactivity of the left middle cerebral artery was measured as −12%.
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teen patients had TCD before PET, and seven patients had
TCD 7 days at the most after PET. Seventeen patients
(71%) had impaired TCD CO2-reactivity, of whom three
had absent CO2-reactivity and three showed a steal
phenomenon. PET studies indicated that haemodynamic
compromise was present in 15 patients (63%), of whom 13
patients were classified as haemodynamic stage 1 (with
decreased CBF in 10, increased CBV in 3, and both
decreased CBF and increased CBV in 2 patients) and 2
patients were classified as stage 2. As an example, Figure 1
shows parametric images of a patient with stage 2 haemo-
dynamic failure. In 12 of the 24 patients (50%), TCD and
PET showed agreement in haemodynamic status. In 10 of
these 12 patients, haemodynamic compromise was demon-
strated by both TCD and PET. In two patients, the flow
state of the brain was normal in both TCD and PET. Of the
12 patients with different haemodynamic assessment inTable 2 Comparison of absolute ipsilateral PET values and he
All patients Impaired CVR
(≤20%)
Norm
(>20
n=24 n=17 n=7
CO2-reactivity (%), mean± SD 15.5 ± 15.9 7.0 ± 8.7 36
CBF (mL/min/100 mL), mean± SD 31.9 ± 5.6 32.3 ± 6.0 30
CBF ratio, mean± SD 0.88 ± 0.09 0.87 ± 0.08 0.
OEF (%), median (IQR) 45.1 (42.2 to 50.9) 45.0 (42.5 to 50.1) 47.8 (
OEF ratio, median (IQR) 1.06 (1.00 to 1.11) 1.06 (1.01 to 1.11) 1.08 (
CBV/CBF, mean± SD 0.10 ± 0.03 0.10 ± 0.03 0.
CBV/CBF ratio, mean± SD 1.27 ± 0.18 1.32 ± 0.15 1.
CBF, cerebral blood flow; CBV, cerebral blood volume; CVR, cerebrovascular reactivi
Mann–Whitney test.TCD and PET, 7 patients with impaired CO2-reactivity
(−4%, 0%, 0%, 5%, 11%, 15%, and 19%, respectively) had a
normal haemodynamic state (stage 0) in PET. Of five
patients with normal CO2-reactivity, 4 were classified as
stage 1 and one as stage 2 based on PET findings. The other
patient with stage 2 haemodynamic failure based on PET
showed steal on CO2-reactivity (−12%). In patients with
agreement between PET and TCD, the median change in
systolic blood pressure during TCD was 0 mmHg (inter-
quartile range (IQR) 25), which did not differ from the me-
dian change in systolic blood pressure of 5 mmHg (IQR 10)
in those without agreement (p=0.850). The median change
in diastolic blood pressure in patients with agreement be-
tween PET and TCD (0 mmHg, IQR 5) did not differ from
the median change in those without agreement (3.5 mmHg,
IQR 10; p=0.257).
In Table 2, PET findings are compared between patients
with and without impaired CO2-reactivity and betweenmispheric ratios with TCD CO2-reactivity
al CVR
%)
p value Absent CVR
or steal
(≤0%)
No absent
CVR or steal
(>0%)
p value Test
n=6 n=18
.0 ± 9.0 −2.7 ± 4.8 21.6 ± 13.5
.9 ± 4.8 0.572 30.8 ± 5.0 32.3 ± 5.9 0.598 t
90 ± 0.12 0.461 0.84 ± 0.09 0.89 ± 0.09 0.178 t
40.2 to 55.2) 0.634 47.6 (42.1 to 58.4) 45.0 (41.5 to 50.8) 0.424 U
0.97 to 1.12) 0.949 1.09 (1.04 to 1.26) 1.05 (0.99 to 1.10) 0.116 U
11 ± 0.03 0.563 0.09 ± 0.04 0.10 ± 0.02 0.266 t
15 ± 0.21 0.035 1.36 ± 0.15 1.24 ± 0.18 0.174 t
ty; IQR, interquartile range; OEF, oxygen extraction fraction; t, Student’s t test; U,
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sured by TCD. No significant differences were found in ab-
solute CBF, OEF, and CBV/CBF values between patients
with impaired and normal CO2-reactivity and between
patients with and without absent CO2-reactivity or steal. A
prolonged mean transit time in the symptomatic hemi-
sphere in relation to the asymptomatic hemisphere (CBV/
CBF hemispheric ratio) was found to be associated with an
impaired CVR (p=0.035).
Figure 2 illustrates that, on visual inspection, ipsilat-
eral/contralateral ratios of CBF, OEF, and CBV/CBF cor-
responded better with CO2-reactivity than absolute
ipsilateral values of CBF, OEF, and CBV/CBF. Neverthe-
less, there was no significant correlation between CO2-Figure 2 Relationship of CO2-reactivity with PET values. Scatter plots s
(middle panel), and CBV/CBF (lower panel). Within each panel, absolute val
right. The grey dots in the panels on the right indicate the three outliers.reactivity and CBF hemispheric ratio (Pearson r= 0.168,
p= 0.432), OEF hemispheric ratio (Spearman r=−0.242,
p= 0.255), and CBV/CBF hemispheric ratio (Pearson
r=−0.368, p= 0.077). Remarkably, three patients with
high CO2-reactivity (indicated by grey dots in Figure 2)
were the main reason for the poor correlations. Two of
them were males aged 45 and 73 years, and the female
patient was 76 years old. The number of days between
TCD and PET was at most 7 days in these three
patients. Only in one of the three patients, blood pres-
sure during TCD increased with 50 mmHg systolic and
20 mmHg diastolic; in the other two, the systolic blood
pressure remained stable or decreased with 15 mmHg,
and the diastolic blood pressure remained stable. Afterhowing the relationships of CO2-reactivity with CBF (upper panel), OEF
ues are shown on the left and ipsilateral/contralateral ratios on the
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nificant correlations were obtained between CO2-re-
activity and CBF ratio (Pearson r= 0.563, p= 0.008), OEF
ratio (Spearman r=−0.542, p= 0.011), and CBV/CBF
ratio (Pearson r=−0.677, p= 0.001).
Discussion
The main finding of this study is that, in patients with
symptomatic ICA occlusion, identification of the presence
or absence of haemodynamic compromise by oxygen-15
PET and TCD CO2-reactivity corresponds in only half of
the patients. This is important as the presence of haemo-
dynamic compromise has been shown to predict recurrent
stroke [1-3] and may play a role in the decision whether or
not to advise revascularization surgery. We did not find a
difference in the change in blood pressure during TCD be-
tween patients with and without agreement between PET
and TCD. Therefore, it is unlikely that an increase in blood
pressure during TCD resulting in an overestimated CO2-re-
sponse is responsible for the incongruent findings between
PET and TCD. After excluding three patients with high
CO2-reactivity, a correlation with the various ipsilateral/Table 3 Overview of studies comparing cerebrovascular react
Author Method 1 Method 2 Sample (n) ICA o
Fujimoto et al. 2002 [29] IMP-SPECT +ACZ 15O-PET 53 18
Herold et al. 1988 [25] Xenon-SPECT + CO2
15O-PET 21 19
Imaizumi et al. 2002 [28] IMP-SPECT +ACZ 15O-PET 27 9
Nariai et al. 1995 [26] Xenon CT+ACZ 15O-PET 11 4
Nemoto et al. 2004 [27] Xenon CT+ACZ 15O-PET 12 12
Sugimori et al. 1995 [24] TCD+CO2
15O-PET 22 2
TCD, transcranial Doppler; CO2, carbon dioxide; ACZ, acetazolamide; CT, computed
reactivity; CBF, cerebral blood flow; OEF, oxygen extraction fraction; CBV, cerebral bcontralateral PET ratios was found, albeit only at a moder-
ate level. It is not clear why these three patients were out-
liers as age or time between TCD and PET were not
different from the other patients.
Previous studies investigating the relationship between
cerebrovascular reactivity and CBF or OEF measured by
PET also included patients with other types of vascular
obstruction other than ICA occlusion and reported con-
flicting results (Table 3). Only one previous study made
the same comparison as we did between TCD CO2-re-
activity with oxygen-15 PET, but they selected 22 patients
with hypertension and diabetes. In concordance with our
findings, this study did not find an association between
increased OEF and decreased TCD CO2-reactivity [24].
Other studies have reported an association between
impaired cerebrovascular reactivity to hypercapnia or
acetazolamide measured with SPECT or stable-xenon CT
studies and increased PET OEF [25-29].
The results of the present study indicate that, in patients
with recently symptomatic ICA occlusion, TCD measure-
ments of the haemodynamic state of the brain cannot be
replaced by oxygen-15 PET and vice versa for identificationivity with CBF or OEF
cclusion Symptoms Agreement between methods
47 Haemodynamic compromise in 75% by method 1,
32% by method 2 (increased OEF, stage 2),
and 64% by method 2 (stage 1).
Correlation CVR (asymmetry index) with
CBF/CBV r= 0.31 (p< 0.05)
Correlation CVR with OEF r=−0.64 (p< 0.0001)
7 Haemodynamic compromise in 29% by method 1
and 19% by method 2 (increased OEF)
Correlation CVR with CBF/CBV r= 0.575 (p< 0.01)
Correlation CVR with oxygen extraction
ratio r=−0.573 (p< 0.01)
22 No data on the number of patients with
haemodynamic compromise
Correlation CVR with CBV r=−0.31 (p< 0.01)
Correlation CVR with OEF r=−0.55 (p< 0.0001)
10 No data on number of patients with
haemodynamic compromise
Correlation CVR with CBV r=−0.50 (p= 0.02)
Correlation CVR with OEF r=−0.65 (p= 0.001)
12 Haemodynamic compromise in 50% by method 1
and 17% by method 2 (increased OEF)
Correlation CVR with OEF r=−0.57 (p= 0.001)
7 Haemodynamic compromise in 52% by method 1
and 9% by method 2 (increased OEF)
Correlation CVR with CBF r= 0.47 (p< 0.05)
Correlation CVR with OEF r= 0.20 (ns)
tomography; PET, positron emission tomography; CVR, cerebrovascular
lood volume.
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explained by important differences between TCD and oxy-
gen-15 PET. First, TCD measures blood flow velocity in
the MCA itself, whereas PET measures perfusion at the
level of the brain tissue. The method of TCD relies on the
assumption that changes in flow velocity are directly pro-
portional to changes in CBF. For that to be true, the cross-
sectional area of the insonated artery needs to remain con-
stant [30,31]. In contrast, PET directly measures CBF, CBV,
and OEF, which are components of the autoregulation it-
self. In addition, TCD measures changes in flow velocity in
response to hypercapnia, whereas PET, according to the
scan protocol in this study, measures haemodynamic para-
meters at rest, i.e., without vasodilatory stimuli. Of the pre-
vious studies that compared the CBF response after a
vasodilatory stimulus measured by SPECT or stable-xenon
CT with TCD reactivity [32-35], one study of 38 patients
with ICA stenosis or occlusion found only a weak relation
[32], and others reported moderate to good correlations
between CBF response after a challenge and TCD cerebro-
vascular reactivity [33-35]. It is possible that the agreement
between TCD and PET in our study would have been bet-
ter if a vasodilatory stimulus had also been included in the
PET studies. An advantage of PET is that it does not only
provide information on perfusion in the MCA territory but
also on the flow state of the other vascular territories of
the brain. TCD and PET do not only measure different
physiologic parameters but also use quite different techni-
ques. As a gold standard for measuring the flow state of
the brain is not yet available, the sensitivity and specificity
of TCD and PET cannot be determined [1,10].
A strength of the present study in comparison with
previous reports is that a more homogenous population
of patients was included as all had recent symptoms of
the hemisphere ipsilateral to an ICA occlusion. In
addition, 92% of patients had ischaemic symptoms after
documented occlusion, which is an important clinical
risk factor for recurrent ischaemic stroke [36]. Further-
more, in contrast to some previous studies [24,25], the
majority of patients in our cohort showed haemo-
dynamic compromise measured by TCD or PET. It is in
this subcategory of patients that accurate identification
of haemodynamic compromise has implications for
prognosis and possible treatment decisions.
This study has some limitations. First, the patients were
not investigated by TCD and 15O-PET on the same day.
Compromised cerebral perfusion can improve over time
[37]. Although the majority of patients (88%) had TCD
and PET within 2 weeks, the time interval between TCD
and PET may have contributed to the poor agreement.
Second, the classification in haemodynamic stages may
be a matter of debate. In the model of Derdeyn et al. [9],
stage 1 was defined as a slight decrease of CBF and
slight increase of OEF with or without increase of CBV,but a cutoff value for a slight difference was not pro-
vided. In another clinical PET study, the patients were
only divided into two groups with a normal or increased
OEF [3]. We defined stage 1 as a decreased CBF or
increased CBV as both are signs of autoregulation. This
study shows that both the comparison of haemodynamic
stages by PET and TCD, as well as absolute values
obtained by PET and TCD, did not show agreement.
Third, ten patients had an additional stenosis or occlu-
sion in the contralateral ICA, which may have influ-
enced the results in hemispheric ratios. Fourth, this
study has a relatively small sample size. However, previ-
ous PET studies in relation to cerebrovascular reactivity
were even smaller consisting of at most 19 patients with
ICA occlusion [25].
Conclusions
The present study shows that, in patients with symptom-
atic ICA occlusion, identification of presence or absence
of haemodynamic compromise by oxygen-15 PET and
TCD CO2-reactivity corresponds in only half of patients.
In future trials, PET and TCD CO2-reactivity measure-
ments cannot be used according to local preference to
identify patients with haemodynamic compromise for
study inclusion.
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